Phan Dillon

Direttore Tecnico/Scientifico/R&S presso IBIO, INC.

Health Technology

Consumer Services

Profilo

Phan Dillon is currently the Vice President, Head-Research & Development at iBio, Inc. Previously, Dr. Dillon worked as the Director-In Vivo Pharmacology at Ferring Pharmaceuticals, Inc. and as the Associate Director-Drug Discovery at Pelican Inc. Dr. Dillon holds undergraduate and doctorate degrees from the University of California, Davis and a doctorate degree from The University of Texas at Austin.

Posizioni attive di Phan Dillon

Società	Posizione	Inizio
IBIO, INC.	Direttore Tecnico/Scientifico/R&S	-

Tutte le posizioni attive di Phan Dillon

Precedenti posizioni note di Phan Dillon

Società	Posizione	Fine
PFENEX INC.	Corporate Officer/Principal	-
Ferring Pharmaceuticals, Inc. Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Phan Dillon

Formazione di Phan Dillon

The University of Texas at Austin	Doctorate Degree
University of California, Davis	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Phan Dillon

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
IBIO, INC.	Health Technology

Aziende private	2
Ferring Pharmaceuticals, Inc. Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ.	Health Technology
Pelican Inc Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA.	Health Technology